Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07794592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants

Name: A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants — clinical trial record (NCT07794592)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-08

View on ClinicalTrials.gov ↗

The main purpose of this study is to compare how much and how quickly olomorasib gets into the bloodstream when it is taken in 2 different ways, and to check for any side effects. For each participant, the study will last about 6 weeks and will include 1 stay in the Clinical Research Unit (CRU) which consists of 7 nights.

Trial Details

NCT Number	NCT07794592
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy Volunteers
Enrollment	24 participants
Start Date	2026-08
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-31